SCHEDULE 13G EPIX PHARMACEUTICALS, INC.

Company

GSK plc

Filed

December 21, 2006

Accession Number

0000893220-06-002683

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →